Filter
1410
Text search:
antibiotic
use
Featured
Recommendations
191
New Publications
372
Language
Document type
No document type
616
Guidelines
278
Studies & Reports
250
Manuals
70
Strategic & Response Plan
57
Fact sheets
54
Training Material
38
Situation Updates
12
Infographics
11
Online Courses
8
Brochures
7
Resource Platforms
7
Videos
2
Countries / Regions
India
117
Kenya
42
South Africa
42
Ethiopia
37
Global
37
Nepal
33
Nigeria
26
Africa
23
Sierra Leone
20
Uganda
20
Tanzania
20
Ghana
19
Bangladesh
19
Western and Central Europe
19
Philippines
15
Malawi
14
Rwanda
12
Latin America and the Carribbean
12
Namibia
11
Zimbabwe
10
Madagascar
10
Myanmar / Burma
10
Haiti
9
Liberia
8
Zambia
7
Syria
7
Burkina Faso
6
Cambodia
6
Mozambique
6
Eastern Europe and Central Asia
6
Eastern Europe
6
Eswatini/ Swaziland
5
Lesotho
5
East and Southern Africa
5
South–East Asia Region
5
Congo, Democratic Republic of
4
USA
4
Indonesia
4
Ukraine
4
Botswana
4
Tajikistan
4
Vietnam
4
Senegal
3
Mali
3
Pakistan
3
South Sudan
3
Germany
3
Thailand
3
Argentina
3
North Macedonia
3
West and Central Africa
3
Middle East and North Africa
3
Western Pacific Region
3
Russia
3
Cameroon
2
Somalia
2
Iraq
2
Jordan
2
Afghanistan
2
China
2
Papua New Guinea
2
Sudan
2
Peru
2
Serbia
2
Colombia
2
Asia
2
Fiji
2
Venezuela
2
Laos
2
Uruguay
2
Spain
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Lebanon
1
Egypt
1
Gambia
1
Malaysia
1
Benin
1
Brazil
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Angola
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Other region
1
Solomon Islands
1
Bhutan
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
502
Clinical Guidelines
215
Women & Child Health
115
Public Health
46
Key Resources
45
Capacity Building
37
Pharmacy & Technologies
17
Toolboxes
AMR
357
TB
76
Rapid Response
65
Pharmacy
65
Caregiver
62
NTDs
54
HIV
42
Planetary Health
40
COVID-19
34
Cholera
27
Ebola
22
Conflict
22
Global Health Education
14
NCDs
14
Refugee
12
Mental Health
11
Disability
9
Specific Hazards
9
Natural Hazards
5
Polio
3
Health Financing Toolbox
1
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
As the nation’s public health leader, the Centers for Disease Control and Prevention (CDC) is actively engaged in a national effort to protect the public’s health from the harmful effects of climate change. Scientists from CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NC
...
This guideline aims to improve the quality of essential, routine postnatal care for women and newborns with the ultimate goal of improving maternal and newborn health and well-being. It recognizes a “positive postnatal experience” as a significant end point for all women giving birth and their n
...
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered
...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca
...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex
...
On September 10, 2022, the Ministry of Health (MOH) announced a cholera outbreak in Aleppo governorate with 15 laboratory confirmed cases reported between August 25 and September 9, 2022. Activities under this plan seek to address the immediate needs stemming from this outbreak and highlight respons
...
The WHO BioHub Biosafety & Biosecurity: criteria and operational modalities sets out the requirements to which laboratories wishing to receive biological materials as part of this international exchange system should abide, to ensure safe and secure operations. These provisions are in accordance wit
...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste
...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El
...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid
...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u
...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da
...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d
...
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres
...
